Clue
Kate Hermans has extensive experience in leadership positions across various sectors, particularly in healthcare and technology. Currently serving as Chair of Clue by Biowink and as a Board Member of Mid-Atlantic Diamond Ventures, Kate has demonstrated a commitment to reproductive health and supporting emerging technology-based companies. Previous roles include Non-Executive Director and Interim CEO at Ambrx, where strategic initiatives led to significant advancements, and Chief Business Officer at 83bar, focusing on patient activation through digital health. With a background that includes Vice President roles at Radius Health and Bristol-Myers Squibb, and senior positions at Pfizer, Kate has consistently driven growth and innovation. Kate's academic credentials include a Master of International Management from Thunderbird School of Global Management and a BA from Wheaton College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Clue
6 followers
Clue is the #1 doctor-recommended period & cycle tracking app available on iOS, Android, and Apple Watch. Across the globe, more than 10 million active users rely on Clue to help understand their bodies better and keep their data safe and private. Clue’s mission is for women and people with cycles to make good choices for themselves, and live full lives not in spite of their biology, but in tune with it. Clue was founded in 2012 by a Danish female entrepreneur, Ida Tin, who is convinced that technology will profoundly change the future of family planning.